Pharmaceutical Industry Blog

Last Updated: September 1, 2026 TL;DR: Moldova gives the clearest answer this series has produced to the question we always ask first, and the answer is unfavourable but precise, which is worth more than a vague encouragement. Legea nr. 153 of 19 June 2025 defines in its own first article the countries it treats as having the same level of requirements for proving quality, safety and efficacy: the European Economic Area states, the United States, the United Kingdom, Switzerla

Last Updated: September 1, 2026 TL;DR: Namibia does not fit either pattern this series has been finding. It is not a market with a closed reference-country list that excludes India, and it is not a market with no list at all. The gazetted regulation creates the recognition hook in deliberately open language — registration granted by “other medicines regulatory authorities recognised by the Council” — and names nobody. The Council's actual list of recognised authorities lives